Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R15CA231339
Texas Tech University Health Sciences Center, School of Pharmacy Office of Sciences Grant
Grant: 2021
National Institutes of Health
Grant: 1R15CA231339-01
Novel Class of Chemotherapeutic Agents for Treatment of Metastatic Triple-negative Breast Cancer
FWCI
3.61
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals